|
Volumn 20, Issue 39, 2001, Pages 5459-5465
|
Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents
a b b |
Author keywords
Cleared fat pad; ErbB2; HC11 mammary cells; NeuT; PKI166; Taxol
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PACLITAXEL;
PHOSPHOTRANSFERASE INHIBITOR;
PK 1166;
PROTEIN TYROSINE KINASE INHIBITOR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
BREAST CARCINOMA;
CANCER INHIBITION;
CANCER MODEL;
CELL TRANSFORMATION;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SCREENING;
ENZYME INHIBITION;
GROWTH INHIBITION;
MOUSE;
NONHUMAN;
ONCOGENE NEU;
PRIORITY JOURNAL;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL DIVISION;
CELL LINE, TRANSFORMED;
CELL TRANSFORMATION, NEOPLASTIC;
DRUG SCREENING ASSAYS, ANTITUMOR;
FEMALE;
GENES, ERBB-2;
MAMMARY GLANDS, ANIMAL;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MICE;
MICE, INBRED BALB C;
NEOPLASM TRANSPLANTATION;
PACLITAXEL;
PYRIMIDINES;
PYRROLES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RECEPTOR, ERBB-2;
|
EID: 0035817742
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1204709 Document Type: Article |
Times cited : (38)
|
References (37)
|